Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Spinal cord tumour misdiagnosed as seropositive neuromyelitis optica spectrum disorder.
Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors.
The ethics of placebo controlled clinical trials in NMO - A balance of risks.
Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome.
Anesthesia for the obstetric patient with multiple sclerosis.
The impact of neuromyelitis optica on the recognition of emotional facial expressions: A preliminary report.
Erratum to: Association Between the Single Nucleotide Polymorphism and the Level of Aquaporin-4 Protein Expression in Han and Minority Chinese with Inflammatory Demyelinating Diseases of the Central Nervous System.
Case-Based fMRI Analysis after Cognitive Rehabilitation in MS: A Novel Approach.
The role of invariant NKT cells in organ-specific autoimmunity.
Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination.
Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome.
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Induced brain plasticity after a facilitation programme for autobiographical memory in multiple sclerosis: a preliminary study.
Smoking increases the risk of multiple sclerosis in Queensland, Australia.
Identifying the amylome, proteins capable of forming amyloid-like fibrils.
Validating archetypes for the Multiple Sclerosis Functional Composite.
Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.
S-Allylmercapto-N-acetylcysteine (ASSNAC) protects cultured nerve cells from oxidative stress and attenuates experimental autoimmune encephalomyelitis.
Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.
Objective duplex ultrasound evaluation of the extracranial circulation in multiple sclerosis patients undergoing venoplasty of internal jugular vein stenoses: A pilot study.
Acute inflammatory myelopathies.
Intestinal Microbiota as Modulators of the Immune System and Neuroimmune System: Impact on the Host Health and Homeostasis.
Epstein-Barr virus in multiple sclerosis.

Pages